
Catherine Booth
2.4K posts

Catherine Booth
@Cath_Booth
Proud northerner, co-founder of Epistem Ltd (but all views my own etc etc).










Our paper was out from npj breast cancer. T-DXd in patients with brain metastases and/or leptomeningeal disease. Median PFS was 16.1 months; 12-month OS rate was 74.9% (total population). In 19 LMC patients, 12-month PFS and OS rates were 60.7% and 87.1%. nature.com/articles/s4152…



Mary was a leader in advocacy. She knew her red flag symptoms but still had to challenge to get a brain MRI. It was discovered she had MBC in the brain. Research has shown that 20% of women with signs & symptoms of MBC were treated for another condition first #DisappearingLives




Quoted in Sky News #EnhertuLowNow buff.ly/465pmm4

METUPUK is dismayed by the NICE decision not to recommend the drug Enhertu (trastuzumab deruxtecan), for routine use on the NHS in England for #metastaticbreastcancer in HER2-low patients... Please see our statement via this link buff.ly/3roQ5Lh #EnhertuLowNow







